Epidemiological data suggest robust associations of high vegetable intake with decreased risks of bladder cancer incidence and mortality, but translational prevention studies have yet to be performed. We designed and tested a novel intervention to increase vegetable intake in patients with non-invasive bladder cancer. We randomized 48 patients aged 50 to 80 years with biopsy-proven noninvasive (Ta, T1, or carcinoma in situ) urothelial cell carcinoma to telephone-and Skype-based dietary counseling or a control condition that provided print materials only. The intervention behavioral goals promoted 7 daily vegetable servings, with at least 2 of these as cruciferous vegetables. Outcome variables were self-reported diet and plasma carotenoid and 24-hour urinary isothiocyanate (ITC) concentrations. We used 2-sample t-tests to assess between-group differences at 6-month follow-up. After 6 months, intervention patients had higher daily intakes of vegetable juice (p=0.02), total vegetables (p=0.02), and cruciferous vegetables (p=0.07); lower daily intakes of energy (p=0.007), (p=0.002) and energy from fat (p=0.06); and higher plasma alphacarotene concentrations (p=0.03). Self-reported cruciferous vegetable intake correlated with urinary ITC concentrations at baseline (p<0.001) and at 6 months (p=0.03). Although urinary ITC concentrations increased in the intervention group and decreased in the control group, these changes did not attain between-group significance (p=0.32). In patients with non-invasive bladder cancer, our novel intervention induced diet changes associated with protective effects against bladder cancer. These data demonstrate the feasibility of implementing Cancer Research.
Translational studies of lifestyle modifications and bladder cancer, however, have yet to be performed. In a randomized clinical trial, we tested a novel intervention to increase vegetable intake in patients with non-invasive bladder cancer.
Materials and Methods

Study population
We recruited 48 patients aged 50 to 80 years at 4 study sites ulcerative colitis, and Crohn's disease); intolerance of cruciferous vegetables; bladder cancer with distant metastases; prior cystectomy or radiotherapy; current oral anticoagulation therapy with coumadin; and unwillingness to adopt a vegetable-rich diet.
Intervention: telephone-and Skype-based dietary counseling
Patients were randomized to 6 months of telephone-or Skype-based (for New Zealand patients, n=1) dietary counseling or a control condition that provided print materials only.
The principle strategy to promote dietary change in the intervention arm was a counseling protocol with individualized, one-on-one assistance tailored to each participant. The counseling protocol followed a step-wise, phased approach employing social cognitive theory. (10, 11) Motivational interviewing techniques were utilized to help participants assume and maintain responsibility for their own behavior change. (12) Similar to a prior study we conducted in prostate cancer patients, (13) we included 12 telephone calls over the 6-month intervention, with more frequent calls occurring during the early phase of the intervention when participants required more support in making dietary change. The protocol specified 5 calls during month one and 3 calls during month two, followed by monthly maintenance calls during months three through six.
The primary intervention behavioral goal was 7 daily vegetable servings, with at least 2 of these as cruciferous vegetables. We defined a serving size as ½ cup cut-up, chopped, or shredded vegetables; ½ cup vegetable sauce or puree; 1 
Outcome variables
Diets were evaluated at baseline and again at 6-month follow-up by a series of 3 separate 24-hour dietary recalls collected interactively via telephone interview. Each set of recalls included two weekdays and 1 weekend day during a 2-week period to provide data on average intake over that time period. To reduce the potential for reporting bias, the assessors were blinded to the randomization allocation. Dietary data was collected and analyzed utilizing Hospital were stored at -80 degrees until shipment to UCSD.
Statistical analysis
The study was designed to have > 80% power to detect a moderate to large 0.7 effect-size (i.e. mean difference in diet change between arms divided by the SD of change) with 50 total participants, based on a 1-sided t-test with alpha=0.05. The primary outcomes were changes in objective dietary biomarkers, namely alpha-carotene and urinary isothyocyanates, since vegetables, especially cruciferous vegetables, were a primary target of the intervention. Secondary outcomes were self-reported dietary intake of vegetables, fruits, grains, and fat. For this pilot feasibility study, no multiple comparisons adjustment for sample-size were made for the multiple outcomes.
We randomized participants in a 3:2 fashion to the dietary intervention (N=30) or control arm (N=18) using a block design. We randomized a larger proportion to the intervention arm in order to specifically and intensively investigate the feasibility of administering the behavior intervention in this pilot trial and to obtain estimates of effect-size and precision for planning a larger trial.
To test if randomization achieved comparable groups at baseline, we compared diet groups on baseline participant characteristics using 2-sample tests. To examine dietary changes, we used 2-sample nonparametric Wilcoxon tests to assess between-group differences from baseline to 6-month follow-up.
We evaluated self-reported dietary values and biomarkers.
We conducted a sensitivity analysis to examine the robustness of results to missing data by fitting a linear mixed-effects model with dietary intake at baseline and 6 months as repeated outcome measures. (19) We included a personspecific random effect to model person-person variability in intake and diet group, time (0, 6months), and the group*time interaction as fixed effects in the models.
A significant diet*group interaction would indicate that dietary changes differed significantly between study arms. We transformed biomarker values to better approximate a Gaussian distribution in these models. We used a 5% significance level for all analyses. 
Results
Baseline characteristics
The groups did not differ significantly in age, BMI, gender, ethnicity, education, time from diagnosis to randomization, or tumor stage (Table 1) .
At 6-month follow-up, 83% of the participants completed the diet recall assessments ( Table 2 ) and 81% (Table 3 ) provided blood and urine samples to complete the biomarker assays. Six (20%) participants in the intervention arm and 2 (11%) in the control arm did not complete the study (Figure 1 ). The reasons for participant discontinuation were as follows: in the intervention group, 1 could not continue due to bladder cancer progression, 1 withdrew due to other medical reasons, 2 could not be contacted by phone, and 2 voluntarily withdrew for unspecified reasons; in the control group, 1 could not continue due to bladder cancer progression and 1 could not be contacted by phone.
Self-reported dietary intake
At 6-month follow-up, intervention patients reported significant increases in daily intakes of vegetable juice and total vegetables and lower daily intakes of total energy (kcal/d) and fat (g/d) compared to control patients. Although not significant at the 5% level, daily intakes of cruciferous vegetables and legumes increased and energy from fat decreased in the intervention compared to the control groups ( 
Dietary biomarkers
At 6-month follow-up, intervention patients demonstrated significant increases from baseline in plasma alpha-carotene concentrations compared to controls.
Although intervention patients also had increases from baseline in plasma lycopene, beta-carotene, and total carotenoids compared to controls, these differences did not attain significance (Table 3) .
Self-reported cruciferous vegetable intake correlated significantly with 24-hour urinary ITC concentrations at both baseline (Spearman r=0.63, p=0.005) and 6-month follow-up (Spearman r=0.45, p=0.03). Although urinary ITC concentrations increased in the intervention arm and decreased in the control arm, these changes did not attain significance among the patients for whom 6-month comparison data were available (Table 3) . Sensitivity analysis using mixed model yielded concordant results (Appendix).
Discussion
In this randomized pilot trial in patients with non-invasive bladder cancer, our novel dietary counseling intervention significantly increased vegetable intake and plasma alpha-carotene concentrations, significantly decreased fat and total energy intake, and marginally significantly increased cruciferous vegetable intake. In the intervention group, self-reported intake of cruciferous vegetables more than doubled (p<0.05 for within group change and p=0.07 for between group change, Table 2 ). This trial is the first clinical study of a dietary intervention for bladder cancer and demonstrates the feasibility of implementing therapeutic, chemopreventive lifestyle modifications in patients with bladder cancer.
The aim of this pilot study was to develop a feasible clinical intervention that produces changes in the diets of bladder cancer patients consistent with the putative benefits of prior epidemiological and pre-clinical data. Although the majority of prior evidence supports a role for dietary modification in primary prevention, (6, 8, 9) at least one study observed a survival benefit for higher crucifer intake among bladder cancer survivors. (7) Moreover, given the relatively high incidence of recurrence and progression, a compelling argument can be made in favor of the clinical relevance of tertiary prevention applications. Approximately 75% to 85% of patients with bladder cancer initially present with non-invasive disease; of these, 50% to 90% will recur or progress to invasive small sample sizes (Figure 1 ). Although the changes were non-significant, total carotenoid and isothiocyanate concentrations in the intervention group increased while those in the control group decreased or remained stable, consistent with the intervention emphasis on cruciferous vegetables. Larger sample sizes would be needed to definitively demonstrate biomarker changes.
In addition, although objective biomarkers are useful metrics, they should not necessarily be regarded as a gold standard for measuring relevant intakes of nutrients in clinical trials, nor should they substitute for diet recall data. Individual variations in variables including, but not limited to, recent macronutrient intake (especially fat), BMI, and ethnicity may potentially influence serum and urinary concentrations of these biomarkers and introduce systematic biases. (27) Biomarkers and dietary recall measures should thus be utilized as complementary metrics.
We believe these results will inform the design of a Phase III trial of dietary modification to prevent recurrence and progression among patients with noninvasive bladder cancer. Specific data we will consider for trial design include the following: first, the carotenoid and ITC biomarker results, which suggest that power calculations for a Phase 3 trial will require consideration of a larger sample size than originally anticipated; second, the adherence data, which suggest an Our intervention is practicable, demands few resource commitments on the part of the patient, and is low-cost to implement among relatively large and geographically diverse study populations. The intervention employs straightforward, rational strategies adopted from social cognitive theory (10, 11) using the techniques of motivational interviewing. (12) differences in most of the biomarkers. Another potential limitation is that it is unclear whether the observed changes in diet and plasma alpha-carotene will persist beyond 6 months. However, a prior study of breast cancer suggests that these changes could continue for at least four years after the initial application of the intervention.(28) Finally, it is possible that recall bias occurred in that the intervention participants may have differentially reported consuming the recommended foods in order to please the interviewer. However, a prior analysis of diet change in breast cancer patients concluded that, while there is a potential increase in systematic error for diet assessment in an intervention group, the validity (i.e., correlation with "true" intake) of self-report is significantly higher during follow-up for intervention versus nonintervention participants.(43) Thus, although the potential for error existed among self-reported diet in the intervention group, so did the potential for increased validity.
Conclusions
In patients with non-invasive bladder cancer, our novel intervention Table 3 . Dietary biomarkers comparing intervention to control at baseline and 6-month follow-up in the Dietary Intervention in Bladder Cancer Study (DIBS). 
